Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
plus dead) labeled
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
plus dead) labeled
2-Methoxyestradiol at low dose induces differentiation of myeloma cells
Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology